Reduced mass and diversity of the colonic microbiome in patients with multiple sclerosis and their improvement with ketogenic diet

Frontiers in Microbiology

Volumn 8, Issue JUN, 2017, Pages

  Swidsinski, Alexander ^a,b   Dörffel, Yvonne ^a   Loening Baucke, Vera ^a   Gille, Christoph ^a   Göktas, Önder ^a   Reißhauer, Anne ^a   Neuhaus, Jürgen ^c   Weylandt, Karsten Henrich ^a   Guschin, Alexander ^d   Bock, Markus ^e  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d 'Cyclone'   (Russian Federation)

^e MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Biofermentation; Colonic microbiota; FISH; Ketogenic diet; Multiple sclerosis

Indexed keywords

KETONE BODY;

ARTICLE; BACTEROIDES; BIOMASS; CLINICAL ARTICLE; CLOSTRIDIUM; COLONIC MICROBIOME; CONTROLLED STUDY; ENTEROBACTERIACEAE; EUBACTERIUM; FAECALIBACTERIUM PRAUSNITZII; FECES ANALYSIS; FERMENTATION; FLUORESCENCE IN SITU HYBRIDIZATION; GLYCEMIC LOAD; HUMAN; INTESTINE FLORA; KETOACIDOSIS; KETOGENIC DIET; LACTOBACILLUS; MICROBIAL DIVERSITY; MULTIPLE SCLEROSIS; NEUROPATHOLOGY; POPULATION ABUNDANCE; RUMINOCOCCUS ALBUS;

EID: 85021409572     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2017.01141     Document Type: Article

References (16)

1. Berer, K., and Krishnamoorthy, G. (2014). Microbial view of central nervous system autoimmunity. FEBS Lett. 588, 4207-4213. doi: 10.1016/j.febslet.2014.04.007
2. Choi, I. Y., Piccio, L., Childress, P., Bollman, B., Ghosh, A., Brandhorst, S., et al. (2016). A diet mimicking fasting promotes regeneration and reduces autoimmunity and multiple sclerosis symptoms. Cell Rep. 15, 136-146. doi: 10.1016/j.celrep.2016.05.009
3. Galland, L. (2014). The gut microbiome and the brain. J. Med. Food 17, 1261-1272. doi: 10.1089/jmf.2014.7000
4. Glenn, J. D., and Mowry, E. M. (2016). Emerging concepts on the gut microbiome and multiple sclerosis. J. Interferon Cytokine Res. 36, 347-357. doi: 10.1089/jir.2015.0177
5. Jangi, S., Gandh, R., Cox, L. M., Li, N., von Glehn, F., Yan, R., et al. (2016). Alterations of the human gut microbiome in multiple sclerosis. Nat. Commun. 7:12015. doi: 10.1038/ncomms12015
6. Kim, D. Y., Hao, J., Liu, R., Turner, G., Shi, F. D., and Rho, J. M. (2012). Inflammation-mediated memory dysfunction and effects of a ketogenic diet in a murine model of multiple sclerosis. PLoS ONE 7:e35476. doi: 10.1371/journal.pone.0035476
7. Loy, A., Maixner, F., Wagner, M., and Horn, M. (2016). ProbeBase-an online resource for rRNA-targeted oligonucleotide probes: new features. Nucleic Acids Res. 35, 800-804. doi: 10.1093/nar/gkv1232
8. Mai, V., Prosperi, M., and Yaghjyan, L. (2016). Moving microbiota research toward establishing causal associations that represent viable targets for effective public health interventions. Ann. Epidemiol. 26, 306-310. doi: 10.1016/j.annepidem.2016.03.011
9. Miyake, S., Kim, S., Suda, W., Oshima, K., Nakamura, M., Matsuoka, T., et al. (2015). Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to clostridia XIVa and IV clusters. PLoS ONE 10:e0137429. doi: 10.1371/journal.pone.0137429
10. Piccio, L., Stark, J. L., and Cross, A. H. (2008). Chronic calorie restriction attenuates experimental autoimmune encephalomyelitis. J. Leukoc. Biol. 84, 940-948. doi: 10.1189/jlb.0208133
11. Suau, A., Rochet, V., Sghir, A., Gramet, G., Brewaeys, S., Sutren, M., et al. (2001). Fusobacterium prausnitzii and related species represent a dominant group within the human fecal flora. Syst. Appl. Microbiol. 24, 139-145. doi: 10.1078/0723-2020-00015
12. Swidsinski, A. (2006). Standards for bacterial identification by fluorescence In situ hybridization within eukaryotic tissue using ribosomal rRNA-based probes. Inflamm. Bowel Dis. 12, 824-826
13. Swidsinski, A., Loening-Baucke, V., Kirsch, S., and Doerffel, Y. (2010). Functional biostructure of colonic microbiota in healthy subjects and patients with diarrhea treated with Saccharomyces boulardii. Gastroenterol. Clin. Biol. 34, 79-92. doi: 10.1016/S0399-8320(10)70025-7
14. Swidsinski, A., Loening-Baucke, V., Schulz, S., Manowsky, J., Verstraelen, H., and Swidsinski, S. (2016). Functional anatomy of the colonic bioreactor: impact of antibiotics and Saccharomyces boulardii on bacterial composition in human fecal cylinders. Syst. Appl. Microbiol. 39, 67-75. doi: 10.1016/j.syapm.2015.11.002
15. Tanca, A., Palomba, A., Pisanu, S., Addis, M. F., and Uzzau, S. (2015). Enrichment or depletion? The impact of stool pretreatment on metaproteomic characterization of the human gut microbiota. Proteomics 15, 3474-3485. doi: 10.1002/pmic.201400573
16. Tremlett, H., Fadrosh, D. W., Faruqi, A. A., Zhu, F., Hart, J., Roalstad, S., et al. (2016). Gut microbiota in early pediatric multiple sclerosis: a case-control study. Eur. J. Neurol. 23, 1308-1321. doi: 10.1111/ene.13026